GlassScriptPrepare for your visit
Yulong Yang
Internal Medicine · Fort Lee, NJ · NPI 1013392919
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,953.13
in general payments reported to CMS, 2019-2025 · $610 in 2025
The $610 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Who reported paying
General payments only, top 6 by amount.
- Amarin Pharma, INC. $573.83
- Amgen INC. $405.50
- Astrazeneca Pharmaceuticals LP $285.15
- Boehringer Ingelheim Pharmaceuticals, INC. $178.14
- Abbvie INC. $126.93
- Lilly USA, LLC $85.57
Drugs and devices associated with these payments
Evenity Farxiga Jardiance Prolia Mounjaro Paxlovid Kerendia Breztri Krystexxa Cologuard Collection Kit Tymlos Keveyis
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Yulong Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/5507316/yulong-yang